back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2024-01-11 14:50 Tx date 2024-01-08 |
$MYCO
Mydecine Innovations Group Inc. |
Bartch, David Joshua
4 - Director of Issuer
Holder: Phantom Technologies Corp. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,500
+100,000 vol $0.035 each |
1,100,000 | |
| Filed 2024-01-11 14:50 Tx date 2024-01-08 |
$MYCO
Mydecine Innovations Group Inc. |
Bartch, David Joshua
4 - Director of Issuer
Holder: Phantom Technologies Corp. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$15,000
+500,000 vol $0.03 each |
1,000,000 | |
| Filed 2023-05-08 12:42 Tx date 2023-05-08 |
$MYCO
Mydecine Innovations Group Inc. |
Michaels, Damon
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-162.50
-500 vol $0.325 each |
111,383 | |
| Filed 2023-05-08 12:37 Tx date 2023-05-08 |
$MYCO
Mydecine Innovations Group Inc. |
Michaels, Damon
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-4,725
-13,500 vol $0.35 each |
90,883 | |
| Filed 2023-05-08 12:37 Tx date 2023-05-08 |
$MYCO
Mydecine Innovations Group Inc. |
Michaels, Damon
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,725
-5,000 vol $0.345 each |
104,383 | |
| Filed 2023-05-08 12:36 Tx date 2023-05-08 |
$MYCO
Mydecine Innovations Group Inc. |
Michaels, Damon
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-680.00
-2,000 vol $0.34 each |
109,383 | |
| Filed 2023-05-08 12:36 Tx date 2023-05-08 |
$MYCO
Mydecine Innovations Group Inc. |
Michaels, Damon
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-250,000
-500 vol $500.00 each |
||
| Filed 2023-05-08 12:35 Tx date 2023-05-08 |
$MYCO
Mydecine Innovations Group Inc. |
Michaels, Damon
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-8,845
-29,000 vol $0.305 each |
111,883 | |
| Filed 2023-04-04 18:35 Tx date 2022-04-20 |
$MYCO
Mydecine Innovations Group Inc. |
Heinzl, Todd
4 - Director of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-226,867 vol |
4,630 | |
| Filed 2023-04-04 18:33 Tx date 2022-02-03 |
$MYCO
Mydecine Innovations Group Inc. |
Heinzl, Todd
4 - Director of Issuer
Direct Ownership
|
Common Shares
46 - Compensation for services
|
$34,101
+48,716 vol $0.70 each |
231,497 | |
| Filed 2023-04-04 18:20 Tx date 2021-10-04 |
$MYCO
Mydecine Innovations Group Inc. |
Heinzl, Todd
4 - Director of Issuer
Direct Ownership
|
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
$127,946
+182,781 vol $0.70 each |
182,781 | |
| Filed 2023-04-04 18:07 Tx date 2022-06-09 |
$MYCO
Mydecine Innovations Group Inc. |
Heinzl, Todd
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-04-04 18:01 Tx date 2021-10-01 |
$MYCO
Mydecine Innovations Group Inc. |
Jetly, Rakesh
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
+4,191 vol |
4,191 | |
| Filed 2023-04-04 18:00 Tx date 2020-11-17 |
$MYCO
Mydecine Innovations Group Inc. |
Jetly, Rakesh
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-12-16 13:25 Tx date 2022-06-09 |
$MYCO
Mydecine Innovations Group Inc. |
Heinzl, Todd
4 - Director of Issuer
Holder: The Governance Box, Inc. (Indirect Ownership)
|
Options
00 - Opening Balance-Initial SEDI Report
|
40,000 | ||
| Filed 2022-12-15 12:42 Tx date 2020-11-17 |
$MYCO
Mydecine Innovations Group Inc. |
Jetly, Rakesh
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
20,000 | ||
| Filed 2022-09-15 02:54 Tx date 2022-04-13 |
$MYCO
Mydecine Innovations Group Inc. |
Stein, Sanford
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-311,987 vol |
6,367 | |
| Filed 2022-09-15 02:48 Tx date 2022-04-13 |
$MYCO
Mydecine Innovations Group Inc. |
Roscow, Robert Fletcher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: RFR Consulting, LLC (Indirect Ownership)
|
Common Shares
37 - Stock split or consolidation
|
-1,666,000 vol |
34,000 | |
| Filed 2022-09-15 02:47 Tx date 2022-04-13 |
$MYCO
Mydecine Innovations Group Inc. |
Roscow, Robert Fletcher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-4,573,253 vol |
93,332 | |
| Filed 2022-09-14 15:08 Tx date 2022-04-13 |
$MYCO
Mydecine Innovations Group Inc. |
Ditto, Larry Dean Jr.
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-763,674 vol |
15,585 | |
| Filed 2022-09-14 14:56 Tx date 2022-04-13 |
$MYCO
Mydecine Innovations Group Inc. |
Michaels, Damon
5 - Senior Officer of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-2,940,000 vol |
60,000 | |
| Filed 2022-09-14 14:55 Tx date 2022-04-13 |
$MYCO
Mydecine Innovations Group Inc. |
Michaels, Damon
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-6,903,242 vol |
140,883 | |
| Filed 2022-09-14 14:40 Tx date 2022-04-13 |
$MYCO
Mydecine Innovations Group Inc. |
Bartch, David Joshua
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-3,038,000 vol |
62,000 | |
| Filed 2022-09-14 14:34 Tx date 2022-04-13 |
$MYCO
Mydecine Innovations Group Inc. |
Bartch, David Joshua
4 - Director of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-18,422,961 vol |
375,979 | |
| Filed 2022-09-14 14:30 Tx date 2021-03-08 |
$MYCO
Mydecine Innovations Group Inc. |
Bartch, David Joshua
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
+4,000,000 vol |
24,400,000 | |
| Filed 2022-05-24 17:45 Tx date 2022-01-11 |
$MYCO
Mydecine Innovations Group Inc. |
Bartch, David Joshua
4 - Director of Issuer
Direct Ownership
|
Common Shares
46 - Compensation for services
|
+500,000 vol |
14,798,940 | |
| Filed 2022-05-24 17:44 Tx date 2021-11-24 |
$MYCO
Mydecine Innovations Group Inc. |
Bartch, David Joshua
4 - Director of Issuer
Direct Ownership
|
Common Shares
46 - Compensation for services
|
+5,298,940 vol |
14,298,940 | |
| Filed 2022-05-24 17:43 Tx date 2021-07-30 |
$MYCO
Mydecine Innovations Group Inc. |
Bartch, David Joshua
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
-200,000 vol |
9,000,000 | |
| Filed 2022-05-24 17:42 Tx date 2021-06-30 |
$MYCO
Mydecine Innovations Group Inc. |
Bartch, David Joshua
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
-300,000 vol |
9,200,000 | |
| Filed 2022-05-24 17:41 Tx date 2021-05-31 |
$MYCO
Mydecine Innovations Group Inc. |
Bartch, David Joshua
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
-300,000 vol |
9,500,000 | |
| Filed 2022-05-24 17:40 Tx date 2021-05-04 |
$MYCO
Mydecine Innovations Group Inc. |
Bartch, David Joshua
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
-10,000,000 vol |
9,800,000 | |
| Filed 2022-05-24 17:39 Tx date 2021-04-30 |
$MYCO
Mydecine Innovations Group Inc. |
Bartch, David Joshua
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
-300,000 vol |
19,800,000 | |
| Filed 2022-05-24 17:39 Tx date 2021-03-31 |
$MYCO
Mydecine Innovations Group Inc. |
Bartch, David Joshua
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
-300,000 vol |
20,100,000 | |
| Filed 2022-05-24 17:38 Tx date 2021-03-08 |
$MYCO
Mydecine Innovations Group Inc. |
Bartch, David Joshua
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
-600,000 vol |
20,400,000 | |
| Filed 2022-05-24 17:37 Tx date 2020-10-21 |
$MYCO
Mydecine Innovations Group Inc. |
Bartch, David Joshua
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
-4,000,000 vol |
21,000,000 | |
| Filed 2022-05-24 17:35 Tx date 2020-05-06 |
$MYCO
Newleaf Brands Inc. |
Bartch, David Joshua
4 - Director of Issuer
Direct Ownership
|
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
$2,650,000
+25,000,000 vol $0.106 each |
25,000,000 | |
| Filed 2022-05-24 17:33 Tx date 2020-02-13 |
$MYCO
Mydecine Innovations Group Inc. |
Bartch, David Joshua
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
-2,529,956 vol |
0 | |
| Filed 2020-05-11 12:05 Tx date 2020-05-06 |
$MYCO
Newleaf Brands Inc. |
Bartch, David Joshua
4 - Director of Issuer
Direct Ownership
|
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
$2,968,000
+28,000,000 vol $0.106 each |
||
| Filed 2020-05-11 12:00 Tx date 2020-05-06 |
$MYCO
Newleaf Brands Inc. |
Bartch, David Joshua
4 - Director of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$2,968,000
+28,000,000 vol $0.106 each |
||
| Filed 2022-04-20 21:23 Tx date 2021-11-25 |
$MYCO
Mydecine Innovations Group Inc. |
Ditto, Larry Dean Jr.
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
50 - Grant of options
|
+779,259 vol |
779,259 | |
| Filed 2022-04-20 19:18 Tx date 2020-12-31 |
$MYCO
Mydecine Innovations Group Inc. |
Ditto, Larry Dean Jr.
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-04-20 19:18 Tx date 2021-11-25 |
$MYCO
Mydecine Innovations Group Inc. |
Ditto, Larry Dean Jr.
5 - Senior Officer of Issuer
Direct Ownership
|
Options Restricted Stock Unit
51 - Exercise of options
|
-779,259 vol |
0 | |
| Filed 2022-04-20 19:17 Tx date 2021-11-25 |
$MYCO
Mydecine Innovations Group Inc. |
Ditto, Larry Dean Jr.
5 - Senior Officer of Issuer
Direct Ownership
|
Options Restricted Stock Unit
50 - Grant of options
|
+779,259 vol |
779,259 | |
| Filed 2022-04-20 19:15 Tx date 2020-12-31 |
$MYCO
Mydecine Innovations Group Inc. |
Ditto, Larry Dean Jr.
5 - Senior Officer of Issuer
Direct Ownership
|
Options Restricted Stock Unit
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-04-11 13:03 Tx date 2020-04-30 |
$MYCO
Mydecine Innovations Group Inc. |
Roscow, Robert Fletcher
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-03-14 16:14 Tx date 2020-04-30 |
$MYCO
Mydecine Innovations Group Inc. |
Roscow, Robert Fletcher
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-04-04 22:14 Tx date 2021-11-24 |
$MYCO
Mydecine Innovations Group Inc. |
Stein, Sanford
5 - Senior Officer of Issuer
Direct Ownership
|
Options Restricted Stock Unit
50 - Grant of options
|
+318,354 vol |
318,354 | |
| Filed 2022-04-04 18:46 Tx date 2021-11-24 |
$MYCO
Mydecine Innovations Group Inc. |
Stein, Sanford
5 - Senior Officer of Issuer
Direct Ownership
|
Options Restricted Stock Unit
51 - Exercise of options
|
-318,354 vol |
0 | |
| Filed 2022-04-04 15:24 Tx date 2021-11-24 |
$MYCO
Mydecine Innovations Group Inc. |
Stein, Sanford
5 - Senior Officer of Issuer
Direct Ownership
|
Options Restricted Stock Unit
51 - Exercise of options
|
+318,354 vol |
||
| Filed 2022-03-31 17:26 Tx date 2021-11-25 |
$MYCO
Mydecine Innovations Group Inc. |
Roscow, Robert Fletcher
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
+4,666,585 vol |
9,333,170 | |
| Filed 2022-03-31 17:25 Tx date 2021-11-25 |
$MYCO
Mydecine Innovations Group Inc. |
Roscow, Robert Fletcher
5 - Senior Officer of Issuer
Direct Ownership
|
Options Restricted Stock Unit
51 - Exercise of options
|
-4,666,585 vol |
0 | |
| Filed 2022-03-31 17:23 Tx date 2021-11-25 |
$MYCO
Mydecine Innovations Group Inc. |
Roscow, Robert Fletcher
5 - Senior Officer of Issuer
Direct Ownership
|
Options Restricted Stock Unit
50 - Grant of options
|
$909,984
+4,666,585 vol $0.195 each |
4,666,585 | |
| Filed 2022-03-31 17:21 Tx date 2021-11-25 |
$MYCO
Mydecine Innovations Group Inc. |
Roscow, Robert Fletcher
5 - Senior Officer of Issuer
Direct Ownership
|
Options Restricted Stock Unit
50 - Grant of options
|
$876,354
+4,494,125 vol $0.195 each |
||
| Filed 2022-03-31 13:39 Tx date 2020-04-30 |
$MYCO
Mydecine Innovations Group Inc. |
Roscow, Robert Fletcher
5 - Senior Officer of Issuer
Direct Ownership
|
Options Restricted Stock Unit
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-03-29 22:38 Tx date 2022-03-21 |
$MYCO
Mydecine Innovations Group Inc. |
Michaels, Damon
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
90 - Change in the nature of ownership
|
+2,550,000 vol |
7,044,125 | |
| Filed 2022-03-29 22:38 Tx date 2022-03-21 |
$MYCO
Mydecine Innovations Group Inc. |
Michaels, Damon
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Emerald Baron, LLC (Indirect Ownership)
|
Common Shares
90 - Change in the nature of ownership
|
-2,550,000 vol |
0 | |
| Filed 2022-03-29 22:36 Tx date 2021-11-25 |
$MYCO
Mydecine Innovations Group Inc. |
Michaels, Damon
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options Restricted Stock Unit
51 - Exercise of options
|
$-876,354.375
-4,494,125 vol $0.195 each |
0 | |
| Filed 2022-03-29 22:35 Tx date 2021-11-25 |
$MYCO
Mydecine Innovations Group Inc. |
Michaels, Damon
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
+4,494,125 vol |
4,494,125 | |
| Filed 2022-03-29 22:34 Tx date 2020-05-11 |
$MYCO
Mydecine Innovations Group Inc. |
Michaels, Damon
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-03-29 22:34 Tx date 2021-11-25 |
$MYCO
Mydecine Innovations Group Inc. |
Michaels, Damon
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options Restricted Stock Unit
50 - Grant of options
|
$876,354
+4,494,125 vol $0.195 each |
4,494,125 | |
| Filed 2022-03-29 22:31 Tx date 2020-05-11 |
$MYCO
Mydecine Innovations Group Inc. |
Michaels, Damon
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options Restricted Stock Unit
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-03-14 16:14 Tx date 2020-04-30 |
$MYCO
Mydecine Innovations Group Inc. |
Roscow, Robert Fletcher
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
4,666,585 | ||
| Filed 2022-03-14 14:39 Tx date 2020-04-30 |
$MYCO
Mydecine Innovations Group Inc. |
Roscow, Robert Fletcher
5 - Senior Officer of Issuer
Holder: RFR Consulting, LLC (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
1,700,000 | ||
| Filed 2021-06-22 16:59 Tx date 2020-09-24 |
$MYCO
Mydecine Innovations Group Inc. |
Bartch, David Joshua
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$651,000
+3,100,000 vol $0.21 each |
3,100,000 | |
| Filed 2021-02-18 18:55 Tx date 2021-01-15 |
$MYCO
Mydecine Innovations Group Inc. |
Connolly, Michael
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-27,000
-50,000 vol $0.54 each |
2,058,298 | |
| Filed 2021-02-18 18:43 Tx date 2021-02-18 |
$MYCO
Mydecine Innovations Group Inc. |
Connolly, Michael
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-165,000
-300,000 vol $0.55 each |
0 | |
| Filed 2021-02-18 18:42 Tx date 2021-02-17 |
$MYCO
Mydecine Innovations Group Inc. |
Connolly, Michael
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-405,000
-750,000 vol $0.54 each |
300,000 | |
| Filed 2021-02-18 18:41 Tx date 2021-02-16 |
$MYCO
Mydecine Innovations Group Inc. |
Connolly, Michael
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-604,978.80
-1,008,298 vol $0.60 each |
1,050,000 | |
| Filed 2020-11-30 12:40 Tx date 2020-09-16 |
$MYCO
Mydecine Innovations Group Inc. |
Michaels, Damon
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+3,000,000 vol |
3,000,000 | |
| Filed 2020-11-30 12:37 Tx date 2020-05-11 |
$MYCO
Mydecine Innovations Group Inc. |
Michaels, Damon
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-11-30 12:36 Tx date 2020-05-11 |
$MYCO
Mydecine Innovations Group Inc. |
Michaels, Damon
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Emerald Baron, LLC (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
2,550,000 | ||
| Filed 2020-08-27 19:35 Tx date 2020-08-18 |
$MYCO
Mydecine Innovations Group Inc. |
Vassev, Nikolai
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
2,010,626 |